74013
document
Bronchial carcinoma . II . Quantitative measurements of the quality of survival . A prospective randomized study of the result of therapy in inoperable patients with advanced disease . Forty-eight bronchial carcinoma patients in clinicoanatomical stage 4 of the disease ( advanced disease ) were randomly assigned to groups for radiotherapy , chemotherapy ( cyclophosphamide ) and placebo treatment , respectively . The results were assessed by the survival time and quality of survival . The median survival time was 4.7 months for radiotherapy , 4.7 months for cyclophosphamide and 1.7 months for placebo . The median total sum of vitagram points was 28.1 for radiotherapy , 20.7 for cyclophosphamide and 6.8 for placebo . When calculated per month , the median sum of vitagram points was 5.9 for radiotherapy , 5.7 for cyclophosphamide and 4.8 for placebo . Statistically the results give no reason to believe that placebo is better than radiotherapy , but it can not be excluded that radiotherapy patients could have a much longer survival . As for cyclophosphamide versus radiotherapy , the differences are to uncertain for any conclusion to be drawn .
74014
Intervention_Physical
radiotherapy
74015
Intervention_Pharmacological
chemotherapy ( cyclophosphamide )
74016
Intervention_Control
placebo
74017
Intervention_Physical
radiotherapy
74018
Intervention_Pharmacological
cyclophosphamide
74019
Intervention_Control
placebo
74020
Intervention_Physical
radiotherapy
74021
Intervention_Pharmacological
cyclophosphamide
74022
Intervention_Control
placebo
74023
Intervention_Physical
radiotherapy
74024
Intervention_Pharmacological
cyclophosphamide
74025
Intervention_Control
placebo
74026
Intervention_Control
placebo
74027
Intervention_Physical
radiotherapy
74028
Intervention_Physical
radiotherapy
74029
Intervention_Pharmacological
cyclophosphamide
74030
Intervention_Physical
radiotherapy
74031
Outcome_Mortality
quality of survival
74032
Outcome_Mortality
survival time
74033
Outcome_Mortality
quality of survival
74034
Outcome_Mortality
median survival time
74035
Outcome_Other
median total sum of vitagram points
74036
Outcome_Other
median sum of vitagram points
74037
Outcome_Mortality
survival
74038
Participant_Condition
Bronchial carcinoma
74039
Participant_Sample-size
Forty-eight
74040
Participant_Condition
bronchial carcinoma